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Graphical abstract 
 
Two truncated analogues of the polyenyl photoprotective xanthomonadin pigments have been synthesised 
utilising an iterative Heck-Mizoroki (HM)/iododeboronation cross coupling approach and investigated as 
models of the natural product photoprotective agents in bacteria. Despite the instability of these types of 
compounds, both analogues proved to be sufficiently stable to allow isolation, spectroscopic analysis and 
biological studies into their photoprotective behaviour which showed that despite their shorter polyene chain 
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length, they retained the ability to protect bacteria from photochemical damage; i.e. incorporation of one 
compound into E. coli provided photoprotective activity against singlet oxygen analogous to the natural 
photoprotective mechanisms employed by Xanthomonas bacteria, answering key questions about what 
minimal functionality is required to impart photoprotection, potentially leading to new classes of 
photoprotective and antioxidants compounds. 
 
Introduction 
Members of the bacterial genus Xanthomonas are the cause of a number of plant diseases e.g. Xanthomonas 
oryzae pv. oryzae (rice blight) and Xanthomonas campestris pv. campestris (black rot of crucifers) and these 
bacteria form characteristic yellow colonies due to the yellow, weakly fluorescent, membrane-bound 
pigments they produce (Figure 1).1-12  The presence of these types of pigments in the cell membranes is key 
to the survival of these types of bacteria on leaf surfaces that are exposed to potentially high levels of UV 
light. Indeed, Starr et al. structurally identified these pigments and hence, recognised the Xanthomonas 
pigments’ similarity to the carotenoids. As a result, they postulated that their biological role may be to 
protect the bacteria from photodamage. Indeed, xanthomonadin 1 (isolated from the bacteria) was shown to 
protect Xanthomonas juglandis strain XJ103 from photodamage, but whether or not the pigment protected 
the bacterium from oxygen-related killing was not determined.13 The Sonti group showed that 
xanthomonadin did indeed display antioxidant properties in Xanthomonas oryzae pv. oryzae in 199712 and 
that it protected membrane lipids from peroxidation. The mechanism of this bacterial survival has been 
investigated by the Poplawsky et al. in the Xanthomonas genus2–11 and in 2000, the role of xanthomonadin in 
Xanthomonas campestris pv. campestris was reported. It was concluded that it is unlikely that the 
xanthomonadin pigments offer protection against direct UV damage, rather they likely offer protection when 
a photosensitiser was present. They also showed that a diffusible factor was needed for xanthomonadin 
production via quorum sensing and that the pigB transcriptional unit was vital for bacterial survival. 2,6 
A number of other related pigments made by different bacteria have also been partially identified, or rather 
proposed in the literature.14–16  The main characteristics of these types of systems (Figure 1) being a long 
polyene chain of varying length (commonly an octaene) flanked by an ester group at one end, a substituted 
phenyl group at the other and the entire natural product being somewhat unstable in air and light. Studies of 
these pigments have provided an insight into the biosynthesis of the xanthomonadins, in particular the 
installation of the bromines on the scaffold. The pigment made by Lysobacter enzymogenes is non-
brominated and the bacterium does not possess a halogenase enzyme, suggesting that such enzymes are 
likely key to the installation of bromide functionalities.14 In fact, the presence of bromide functions in such 
molecular systems is interesting from a chemical, photophysical and mode of action standpoint. Presumably, 
following initial formation of a singlet excited state upon UV irradiation, the presence of a bromine atom(s) 
in xanthomonadin-type systems would be expected to lead to a large increase in the rate of spin-forbidden 
intersystem crossing (ISC) to the triplet form by means of interaction with the bromine atom's large orbital 
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angular momentum; the so-called heavy atom effect.17 This process could offer considerable advantages in a 
molecule whose function is as a photoprotective agent. Most notably, singlet-singlet excitation processes 
have previously been shown to operate upon irradiation of carotenoids18 and this has the potential to lead to 
damaging photosensitised reactions within bacterial cells. Rapid conversion from singlet to triplet excited 
states in order to avoid this could therefore be beneficial. Additionally, the presence of a heavy atom is 
known to decrease the lifetime of the triplet states formed in such pathways,19,20 resulting in the further 
reduction of the risk of unwanted triplet-triplet photosensitised reactions and leading to an increased rate of 
regeneration of the photoprotective agent. Hence, probing such systems and models thereof, has potential 
repercussions for understanding and in future, designing photoprotective systems. 
 
Xanthomonadin pigments are also of potential interest for a number of other reasons beyond immediate 
structure-activity aspect as bacterial photoprotective systems, raising a number of intriguing questions, 
including understanding why such long chain polyenes are made by these bacteria when perhaps, simpler, 
more stable photoprotective compounds could be accessible. Additionally, and perhaps more importantly, it 
is necessary to understand the survival mechanisms of such virulent plant pathogens, and there is an 
increasing body of evidence suggesting a role of antioxidants in combatting disease. This could therefore 
lead to possible applications in neurodegenerative and inflammatory diseases such as atherosclerosis, and in 
cancer (amongst others21-23), demonstrating a clear benefit of understanding the functionality behind the 
photoprotective ability of this class of compounds. Ultimately this understanding could perhaps be used as a 
design template from which to harness their reactivity though the synthesis of more accessible analogues, 
generating potentially novel types of antioxidants and photoprotective agents in general. 
_______________________________________________________________________ 
Figure 1 Images of Xanthomonas sp. GBBC2252 and the structure of isolated xanthomonadin pigment 1 with the 
characterisation data obtained by Andrewes et al.13,24,25 (image bottom left is a confocal fluorescence micrograph 
showing xanthomonadin fluorescence at the cell envelope). 
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________________________________________________________________________ 
 
One of the key challenges for any synthesis and investigation of the xanthomonadin pigments is the lack of 
complete, high quality, spectroscopic characterisation. This lack of completely convincing structural 
information, as well as a lack of stability studies, means that in most cases synthetic, stability and biological 
studies are required.22 Interestingly, one of the few systems mostly characterised to a reasonable extent 
(though some years ago now) is xanthomonadin 1, with some reported low resolution 1H NMR data, along 
with ESI and UV-Vis data (see Figure 1).13,24,25 Evidence for a debrominated xanthomonadin methyl ester 
analogue 2b was also obtained, but only in the form of mass spectrometry and UV-Vis spectroscopy.13,24 The 
lack of stability and basic structural information suggests a potential synthetic challenge and goal, and hence, 
coupled with their role as photoprotective agents, makes these systems intriguing synthetic targets as they 
stand, but also, a possible basis for the design of novel photoprotective/antioxidants species. Hence, studies 
were undertaken to understand why polyenic systems typified by xanthomonadins of general type 1 have not 
been prepared to date, why Nature might want to make such seemingly unnecessarily complex and long 
polyenic systems to use as antioxidants, and therefore, whether one could simplify the design and still retain 
antioxidant properties. In this paper, we report synthetic studies working towards analogues of 
xanthomonadin 2, through the synthesis of simpler, shorter systems that are sufficiently stable and retain the 
photoprotective properties of the natural system. 
Results and discussion 
Synthesis of truncated model xanthomonadin analogues 
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Our envisaged disconnection of xanthomonadins such as 226 involved utilising the flexibility of our Heck-
Mizoroki/iododeboronation (HM/IDB) methodology as an iterative process by which to efficiently construct 
polyenyl intermediates. The key strategic aim was to assemble building blocks of whichever length imparts 
the greatest stability and assemble these using palladium cross-coupling chemistry, i.e. as outlined in Scheme 
1a.27–31 Having already established routes to key styrenyl building blocks and performed preliminary 
investigations into their cross-coupling,26 we decided to focus on the synthesis of two truncated model 
compounds. These shorter systems would enable us to test out both final cross-coupling conditions on 
systems more like the final natural product pigments, and to probe the functionalities and polyene chain 
length required to impart photoprotective activity. In designing these new synthetic target analogues 
(Scheme 1), we aimed to better understand the minimal polyene chain necessary for imparting 
photoprotective biological activity, since the reported pigments contain mostly octaenes, with some 
heptaenes and hexaenes, but literature searches did not reveal any shorter polyene chain length systems. As a 
result, we aimed to synthesise pentaenyl models without the bromine substituent on the polyene component, 
with a view to ascertaining their photoprotective potential. Therefore, we designed two models systems: 
pentaene 13, a debrominated shorter analogue of the xanthomonadin system, and tetraeneyne 12, with an 
alkyne next to the aryl group and a tetraenyl chain conjugated to the ester function (see Scheme 1b). Access 
to systems 12 and 13 could be envisaged by starting with styrenyl building blocks and vinyl iodide 7 (i.e. as 
previously reported26,32). 
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______________________________________________________________________________________ 
Scheme 1 a) Retrosynthetic strategy for xanthomonadin pigments 2 synthesis; b) Proposed synthesis of xanthomonadin 
analogues 12 and 13. 
 
_______________________________________________________________________ 
 
Following this synthetic plan (Scheme 1), HM/IDB methodology was indeed successfully utilised to furnish 
the key tetraenyl intermediate 11, in 20% overall yield (average of 76% per step over 6 steps (see Scheme 2). 
Whilst tetraene 11 was unstable in air and light, this intermediate could be stored under argon at -18 °C for 
up to two months. 
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______________________________________________________________________________________ 
Scheme 2 Syntheses of truncated model xanthomonadin analogues 12 and 13 
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________________________________________________________________________ 
Styrenyl building blocks 19 and 20 were synthesised as reported elsewhere,26 via Sonogshira and Suzuki-
Miyaura cross-couplings to give the desired target compounds 12 and 13. Whilst both final couplings (Figure 
3) to derive compounds 12 and 13 proceeded with high conversion, final isolation and therefore isolated 
yields were moderate due to the instability of the final products on silica gel, highlighting the inherent 
instability of even shorter chain analogues. Nevertheless, pentaenyl analogue 13 was successfully obtained 
by Suzuki-Miyaura cross-coupling of tetraenyl iodide 7 with styrenyl building block 20 in a 34% yield, and 
alkynyl tetraenyl analogue 12 by Sonogashira cross-coupling from styrenyl building block 19 in a 56% yield 
(Scheme 2). Other analytical data, especially NMR data, for truncated model xanthomonadin analogues 12 
and 13 was consistent with those reported for xanthomonadin 1, as highlighted in Table 1. 1H NMR data for 
analogues 12 and 13 shows a good correlation with the NMR data reported for xanthomonadin 1 (see Figure 
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1). The spectra for both these analogues 12 and 13 shows additional peaks with smaller alkene couplings, 
suggesting a small proportion of cis-trans (E-Z) isomerism in one of the double bonds (see Tables 1a and 
1b); a proposal which has evidence from UV-Vis spectroscopy (vide infra).  
______________________________________________________________________________________ 
Table 1 detailing: 1a) 1H NMR data for xanthomonadin model 12; 1b) 1H NMR data for xanthomonadin model 13; 3) UV-
Vis and fluorescence data for xanthomonadin 1 and models 12 and 13. 
Table 1a 1H NMR data for analogue 12 Table 1b 1H NMR data for analogue 13 
Entry  Dehydro-tetraen-yne analogue 12 δH 
 Minor component 
(~5%), new identifiable 
signals δH 
Pentaene analogue 13 
δH 
Minor component 
(11%) δH 
1 5.89 (1H, d, J 15.2 Hz) 5.74 (1H, d, J 10.5 Hz) 
5.91 (2H, dd, J 15.3, 6.1 
Hz) 5.72 (1H, d, J 11.2 Hz) 
2 6.37 (2H, dd, J 14.7, 11.2 Hz) 7.64 (1H, d, J 8.1 Hz) 6.29-6.54 (3H, m) 5.74-5.79 (1H, m) 
3 6.41-6.52 (3H, m) 7.74 (1H, d, J 7.9 Hz) 6.60 (1H, dd, J 14.8, 10.5 Hz) 6.21 (1H, t, J 11.5 Hz) 
4 6.55 (1H, d, J 15.5 Hz)  
6.75 (1H, dd, J 15.4, 
10.4 Hz) 7.78 (1H, d, J 12.4 Hz) 
5 6.62 (1H, dd, J 14.7, 11.2 Hz)  6.89-6.99 (2H, m) 7.82 (1H, d, J 12.0 Hz) 
6 6.80-6.85 (1H, m)  7.28-7.39 (1H, m)  
7 6.87-6.93 (2H, m)  7.49 (1H, dd, J 11.4, 8.3 Hz)  
 
Table 2 UV-Vis and fluorescence data for xanthomonadin 1 and models 12 and 13, along with calculated λmax values 
 
aEffect of adding a 30 nm contribution for a bromine function attached to the polyene in the a-aryl position. 
_________________________________________________________________________________  
 
Equation 1           lmax = 114 + 5M + n(48.0 - 1.7n) - 16.5Rendo - 10Rexo 
Where: n = the number of conjugated double bonds; M = the number of alkyl or alkyl-like substituents; Rendo = the 
number of rings with endocyclic double bonds; Rexo = the number of rings with exocyclic double bonds 
_________________________________________________________________________________ 
 
Key findings from comparing of the spectral data in Tables 1a and 1b for compounds 12  and 13 with that of 
xanthomonadin 1 are: 1) That the absorption maxima for analogues 12 and 13 are lower than those of 1, 
consistent with the shorter conjugated polyene chain; 2) That the decrease in absorption maximum is greater 
for yne-tetraene 12 than for pentaene 13, suggesting a longer effective conjugated length in the pentaene 
(vide infra); 3) That application of Fieser-Kuhn rules33 (Equation 1), which were developed for related 
carotenoids, provide a reasonable comparison for the absorptions estimated for xanthomonadin 1 (note that 
Entry 
Compound UV-Vis absorption/nm 
λmax 
(calc.)/nm Emission/nm 
1 Br
OMe
Br 1
O
O
 
453, 482 (CHCl3) 459 (489a) - 
2 
OMe
Br
CO2Me
12
 
397, 417 (CHCl3) 417 
498, 527, 566, 
594 
3 
OMe
Br
CO2Me
13
 
370, 391 (Et2O) 392 440, 468, 494 
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the bromine substituent on the polyene can be expected to add ca. 30 nm to the calculated λmax34) versus the 
two analogues. Indeed, the calculated λmax values for 12 and 13 correspond well with the lowest energy λmax 
observed; 4) That the minor, higher energy (i.e. shorter wavelength) peaks are consistent with some trans- to 
cis-isomerisation. Such a phenomenon is well established (e.g. trans- to cis-stilbene interconversion gives 
two λmax's of 307 and 276 nm, respectively35) and in systems herein it appears likely that the lower 
absorptions (453 for xanthomonadin, 397 for 12, and 370 for 13 (Table 2) are due to the minor cis-isomer 
being present in equilibrium, and indeed, this is further supported by 1H NMR data which is consistent with 
the isomerised alkene being the g,d-double bond relative to the ester carbonyl; 5) The most accurate 
calculation of λmax for yne-tetraene 12 comes from assuming that the alkyne allows conjugation to continue 
throughout the molecule but does not increase the conjugated length in itself (411 nm being obtained if it is 
counted as an additional alkene unit), which is a potentially important consideration when using such 
functional groups in the synthesis of stable polyene analogues. 
Exposure of E. coli cells with truncated xanthomonadin analogues 12 and 13 
Xanthomonadin 1 is weakly fluorescent, allowing the location and relative concentration of xanthomonadin 
1 to be probed in vivo by fluorescence microscopy.  We recorded confocal fluorescence images of four wild-
type Xanthomonas strains using excitation and emission wavelengths appropriate for xanthomonadin 1 
(Figure 2). Xanthomonas arboricola GBBC2191 has larger cells than the other strains and showed relatively 
strong xanthomonadin 1 fluorescence (Figure 2a). The remaining three strains that we examined all have 
smaller cells and showed weak, but detectable, fluorescence from the cell surface layers, as exemplified by 
Xanthomonas sp. GBBC2252 (Figure 2b-d). Unlabelled E. coli cells showed no detectable fluorescence 
when imaged with the same settings (Figure 2g). However, exposure (i.e. staining) to pentaenyl analogue 13, 
followed by washing off, the E. coli cells showed a fluorescence signal that was just a little lower than that 
seen in Xanthomonas sp. GBBC2252, although considerably less than that seen in Xanthomonas arboricola 
(Figure 2e-f). This showed that compound 13 was readily taken up into the these cells, and was incorporated 
into all the E. coli cells in the suspension (Figure 2f). Doubling the concentration of analogue 13 did not 
noticeably increase the labelling of the E. coli cells (not shown). Indeed, the resulting images in Figure 2 
suggest that incubation with analogue 13 solution results in incorporation of 13 into the E. coli membranes at 
levels comparable to the native levels in some Xanthomonas species. By contrast, a similar incubation with 
alkynyl tetraenyl analogue 12 solution did not result in any detectable incorporation into E. coli cells, 
although fluorescence was observed in small crystals or aggregates close to the cells (Figure 2h). It appears 
that analogue 12 may not be bioavailable as a result of crystallisation under the conditions of the exposure of 
the E. coli experiment. 
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__________________________________________________________________________________ 
Figure 2 Xanthomonadin fluorescence from Xanthomonas species and E. coli loaded with compounds 12 or 13 (scale-
bars 5 μm): a. Fluorescence image of Xanthomonas arboricola GBBC2191; b. Fluorescence image of Xanthomonas sp. 
GBBC2252 [same intensity scale as (a) for comparison]; c. Fluorescence image of Xanthomonas sp. GBBC2252 
[intensity-scale enhanced by a factor of 8 compared to (a) and (b)]; d. Merged bright-field and fluorescence image of 
Xanthomonas sp. GBBC2252; e. Fluorescence image of E. coli cells loaded with exogenous 13 [same intensity scale as 
(c)]; f. Merged bright-field and fluorescence image of E. coli cells loaded with exogenous 13; g. Merged bright-field and 
fluorescence image of unlabelled E. coli cells [same intensity scale as (f)]; h. Merged bright-field and fluorescence image 
of E. coli cells loaded with exogenous 12 [same intensity scale as (g)]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3 Effect of pre-incubation with compounds 12 and 13 on the survival rates of E. coli cells following exposure to 
light in the presence of Rose Bengal (n = number of replicate experiments). Each experiment involved counting plates 
which contained ca. 50-100 colonies when untreated cells were plated out. Control: cells without addition of a 
xanthomonadin analogue, Survival rates are relative to cells not exposed to Rose Bengal and light. 
 
Treatment Mean survival rate ± SD T-test (vs control) 
Control 0.56 ± 0.13 (n = 6)  
12 0.37 ± 0.25 (n = 3) p = 0.15 
13 0.95 ± 0.06 (n = 3) p = 0.002 
__________________________________________________________________________________ 
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Truncated xanthomonadin analogue 12 confers photoprotection to E. coli 
To test whether incorporation of analogues 12 and 13 into E. coli cells confers protection against reactive 
oxygen species (ROS), we measured cell survival rates following a treatment with Rose Bengal, which is a 
potent source of singlet oxygen when illuminated. Treatments with Rose Bengal in the dark, or with light in 
the absence of Rose Bengal, had no significant effect on cell survival (not shown). However, treatment with 
light in the presence of Rose Bengal killed nearly half the cells under our conditions, as judged from colony 
counts (Table 3). Remarkably, pre-incubation with pentaenyl analogue 13 conferred essentially complete 
protection against the ROS treatment, with no significant cell death observed. However, alkynyl tetraenyl 
analogue 12 conferred no protection against the ROS treatment (Table 3). 
Pentaenyl analogue 13 can also be added exogenously to E. coli and is incorporated into the cell at levels 
comparable to those found in Xanthomonas species (Fig. 2). Incorporation of 13 in this way into E. coli 
confers strong protection against ROS, providing a direct demonstration of the efficacy of 13 as a ROS 
quencher in a biological context. Alkynyl tetraenyl model 12 was not detectably incorporated into E. coli 
cells following a similar incubation to that used for 13 and this lack of bioavailability is likely due the 
observed formation of crystalline aggregates that could well prevent take up of this particular compound, 
unlike the more bioavailable compound 13 (Fig. 2). From that perspective, it would not be surprising that 
model 12 did not confer any significant protection against ROS, because it was not sufficiently bioavailable 
in the culture conditions used. This reinforces the fact that the xanthomonadin (or synthetic analogue) has to 
be actually be incorporated into the cell to confer protection, i.e. just quenching ROS in the surrounding 
medium is not sufficient. 
Conclusions 
Truncated models of xanthomonadin pigments 1 and 2 were successfully synthesised and their 
photoprotective activity analysed in E. coli. The spectroscopic data obtained supports the characterisation 
previously obtained for xanthomonadin, and is consistent with the shorter chain length of these molecules. 
Pentaenyl analogue 13 was observed to be incorporated into the cell membrane and able to impart 
photoprotective activity analogous to that of the natural product. Alkynyl tetraenyl analogue 12, however, 
was not incorporated, forming crystalline aggregates outside of the cells, and did not impart increased 
protection of E. coli. The activity of debrominated pentaenyl analogue 13 shows that the presence of the 
bromine located on the polyene system in xanthomonadin 1 is not necessary for activity, and more 
importantly, it also shows that a pentaene is sufficient to impart photoprotection. This observation leaves us 
to hypothesise that the role of the bromine might be to impart stability to the polyene chain and to tune 
photoactivity through increase intersystem crossing through the heavy atom effect (vide supra), rather than 
being absolutely necessary for activity.  
Pentaenyl analogue 13 has been shown to be a suitable truncated model for the xanthomonadin pigment class 
of compounds, which should allow for the further study of the photoprotective abilities of this interesting 
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family of plant pathogens. Further studies applying this type of methodology is likely to enable the test for 
protection against ROS conferred by other synthetic variants of the xanthomonadins in more detail and to 
establish whether the antioxidant properties of this class of compounds can be utilised in other therapeutic 
contexts, including as novel antioxidants.  
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